GPT and metabolic dysfunction-associated steatotic liver disease: These findings are consistent with the results of Khoshbaten et al., indicating that a three-month supplementation of NAC (1200 mg/day) can decrease ALT levels and spleen size in patients with NAFLD, leading to an improvement in fatty infiltration due to NAC’s capacity to inhibit lipid peroxidation propagation, which is evident in its role in preventing the onset of NAFLD [48].